Ubs Group Ag Pharming Group N.V. Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Pharming Group N.V. stock. As of the latest transaction made, Ubs Group Ag holds 52 shares of PHAR stock, worth $424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52Holding current value
$424% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding PHAR
# of Institutions
5Shares Held
43KCall Options Held
0Put Options Held
0-
Cowen Prime Advisors LLC22.5KShares$183,4980.09% of portfolio
-
Silverberg Bernstein Capital Management LLC Armonk, NY17.7KShares$144,6900.18% of portfolio
-
Morgan Stanley New York, NY2.8KShares$22,8760.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $533M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...